CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

Imagine you're a molecular biologist wanting to launch a project seeking treatments for a newly emerging disease. You know ...

When the covid madness was imposed upon the world five years ago, the lockdown advocates claimed they were just “doing ...

Since the start of the SARS-CoV-2 pandemic, several variants of the virus have developed into Variants of Concern (VOCs), as ...

The results showed that both SARS-CoV and SARS-CoV-2 envelopes have a spherical morphology, with the structural proteins forming multiple string-like islands in the membrane and clusters between ...

SARS-CoV-2 ribonucleic acid was present at 84 anatomical sites in significantly greater amounts among respiratory tissues than other tissues. SARS-CoV-2 RNA levels among early cases, mid-cases ...

Antibody responses to new SARS-CoV-2 variant infections and vaccinations are powerfully shaped by prior exposures to earlier SARS-CoV-2 vaccines, according to a new study from the Perelman School ...

In the SARS-CoV-2 Immunity and Reinfection Evaluation (SIREN) study, which involved a large cohort of asymptomatic health care workers who underwent polymerase-chain-reaction (PCR) testing every 2 ...

Sarbecoviruses—the group of coronaviruses that includes both SARS-CoV-1 and SARS-CoV-2—have long circulated in horseshoe bats across Western China and Southeast Asia.

SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Nature Communications, 2021; 12 (1) DOI: 10.1038/s41467-021-26910-8 ...